U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07494656) titled 'A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany' on March 20.
Brief Summary: This observational study aims to describe the characteristics, health outcomes, and epidemiology of individuals diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM) in Germany.
ATTR-CM is a rare and serious heart disease caused by the buildup of an abnormal protein called transthyretin in the heart muscle. This can lead to heart failure and other cardiovascular complications.
This is a retrospective, non-interventional study based on anonymized statutory health insurance claims ...